This inventor holds 1 USPTO granted patent. Top assignee: The Chinese University of Hong Kong. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Rossa Wai Kun Chiu: Innovator in Fetal Chromosomal Diagnosis
Introduction
Rossa Wai Kun Chiu is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of genetic diagnostics, particularly in the area of fetal chromosomal aneuploidy detection. His innovative work has the potential to improve prenatal care and outcomes for expectant mothers.
Latest Patents
Rossa Wai Kun Chiu holds a patent for a groundbreaking method titled "Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing." This invention provides methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. The process involves sequencing nucleic acid molecules from the biological sample, allowing for the determination of respective amounts of clinically relevant chromosomes and background chromosomes. By comparing derived parameters to cutoff values, the invention classifies the existence of fetal chromosomal aneuploidy.
Career Highlights
Rossa Wai Kun Chiu is affiliated with The Chinese University of Hong Kong, where he continues to advance research in genetic diagnostics. His work has garnered attention for its innovative approach to prenatal testing, which could lead to earlier and more accurate diagnoses.
Collaborations
Rossa has collaborated with notable colleagues in his field, including Yuk-Ming Dennis Lo and Kwan Chee Chan. Their combined expertise contributes to the advancement of research in fetal diagnostics and genetic testing.
Conclusion
Rossa Wai Kun Chiu is a key figure in the field of genetic diagnostics, with a focus on improving prenatal care through innovative technologies. His contributions are paving the way for advancements in the detection of fetal chromosomal abnormalities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
